NCT03271177

Brief Summary

The purpose of this study is to determine if the routine use of a sheathless 7F guide catheter for transradial percutaneous coronary intervention (TR PCI) is non-inferior to a 6F sheath/guide combination with regards to radial artery injury (radial artery intimal-medial-adventitial thickening). To evaluate the radial artery, ultrahigh resolution ultrasonography (55 mHz) will be used to accurately quantify radial artery intimal-medial-adventitial thickness (IMT) at baseline and 90 days. A non-inferiority analysis will be performed to compare the degree of radial artery IMT at 90 days between the 7F sheathless guide approach and the 6F sheath/guide combination.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at below P25 for not_applicable coronary-artery-disease

Timeline
Completed

Started Feb 2016

Shorter than P25 for not_applicable coronary-artery-disease

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 25, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 13, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 13, 2017

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 23, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 1, 2017

Completed
Last Updated

September 1, 2017

Status Verified

August 1, 2017

Enrollment Period

1 year

First QC Date

August 23, 2017

Last Update Submit

August 31, 2017

Conditions

Keywords

transradial percutaneous coronary intervention

Outcome Measures

Primary Outcomes (1)

  • Radial artery access site intimal-medial thickness (IMT)

    The incidence of other vascular complications such as radial artery occlusion, pseudo-aneurysms, radial artery diameter, and radial artery dissections will also be assessed.

    90-day

Secondary Outcomes (5)

  • Procedural Success Rate

    up to 24 hours

  • Major Adverse Cardiac Events (MACE)

    from date of PCI until date of death, MI or urgent revascularization, whichever came first, assessed up to 72 hrs

  • Fluoroscopy Time

    During PCI procedure (from beginning of procedure until end)

  • Number of Guide Catheters Used

    During PCI procedure (from beginning of procedure until end)

  • Frequency of Cross-over from Radial Access to Femoral Access

    During PCI procedure (from beginning of procedure until end)

Study Arms (2)

7F Sheathless Guide Catheter

EXPERIMENTAL

Patients in this arm will undergo their percutaneous coronary intervention using a 7F Sheathless guide catheter

Device: 7F sheathless Guide Catheter

6F Sheath/Guide Catheter Combination

PLACEBO COMPARATOR

Patients in this arm will undergo their percutaneous coronary intervention using a 6F Sheath/guide combination

Device: 6F Sheath/Guide Catheter Combination

Interventions

Transradial PCI will be performed with a 7F sheathless Guide Catheter

7F Sheathless Guide Catheter

Transradial PCI will be performed with a 6F Sheath/Guide Catheter Combination

6F Sheath/Guide Catheter Combination

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 or above with coronary artery disease
  • Scheduled for transradial PCI

You may not qualify if:

  • Has had prior transradial access for heart catheterization or PCI in same radial artery as planned access site
  • Not willing to undergo follow-up ultrasound examinations
  • Acute ST elevation myocardial infarction or other emergent PCI
  • Inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Wayne B Batchelor, MD, MHS

    Tallahassee Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 23, 2017

First Posted

September 1, 2017

Study Start

February 25, 2016

Primary Completion

March 13, 2017

Study Completion

March 13, 2017

Last Updated

September 1, 2017

Record last verified: 2017-08

Data Sharing

IPD Sharing
Will not share